|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions affects response to substance decreases activity increases secretion decreases expression decreases uptake |
ISO EXP |
ABCB1 gene affects the reaction [CYP2C19 gene affects the susceptibility to clopidogrel] ABCB1 gene affects the susceptibility to clopidogrel; ABCB1 gene polymorphism affects the susceptibility to clopidogrel; ABCB1 gene SNP affects the susceptibility to clopidogrel clopidogrel results in decreased activity of ABCB1 protein ABCB1 protein results in increased secretion of clopidogrel clopidogrel results in decreased expression of ABCB1 mRNA; clopidogrel results in decreased expression of ABCB1 protein ABCB1 protein results in decreased uptake of clopidogrel [Aspirin results in increased expression of ABCB1 protein] which results in decreased uptake of clopidogrel |
CTD |
PMID:17112805 PMID:19106083 PMID:19934793 PMID:20180610 PMID:21900887 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5AP mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
|
|
G |
Arhgap31 |
Rho GTPase activating protein 31 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of ARHGAP31 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr11:62,038,635...62,151,564
Ensembl chr11:62,038,635...62,151,564
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
decreases secretion |
ISO |
clopidogrel results in decreased secretion of BDNF protein |
CTD |
PMID:21803431 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
C4b |
complement C4B |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of C4B mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
Cabin1 |
calcineurin binding protein 1 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of CABIN1 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr20:12,893,314...13,015,357
Ensembl chr20:12,893,358...13,015,357
|
|
G |
Camkk2 |
calcium/calmodulin-dependent protein kinase kinase 2 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of CAMKK2 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
increases expression |
ISO |
clopidogrel results in increased expression of CCL11 mRNA |
CTD |
PMID:19155974 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
clopidogrel results in increased expression of CCL4 mRNA |
CTD |
PMID:16856976 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
clopidogrel results in increased expression of CCL5 mRNA |
CTD |
PMID:16856976 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Cd40lg |
CD40 ligand |
multiple interactions decreases expression |
ISO |
clopidogrel inhibits the reaction [Adenosine Diphosphate results in increased expression of CD40LG protein] clopidogrel results in decreased expression of CD40LG protein Clopidogrel inhibits the reaction [Adenosine Diphosphate results in increased expression of CD40LG protein]; Clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of CD40LG protein] |
CTD |
PMID:11297035 PMID:17043144 PMID:19155974 PMID:30537341 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Clcn7 |
chloride voltage-gated channel 7 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of CLCN7 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr10:14,151,758...14,177,130
Ensembl chr10:14,151,758...14,177,130
|
|
G |
Csf2rb |
colony stimulating factor 2 receptor subunit beta |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2RB mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Clopidogrel results in decreased activity of CYP1A1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases oxidation |
ISO |
CYP1A2 protein results in increased oxidation of and results in increased cleavage of Clopidogrel metabolite; furafylline inhibits the reaction [CYP1A2 protein results in increased oxidation of Clopidogrel] CYP1A2 protein results in increased oxidation of clopidogrel |
CTD |
PMID:19170597 PMID:19812348 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
Clopidogrel results in decreased activity of CYP1B1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases oxidation increases expression multiple interactions |
ISO |
CYP2B6 protein results in increased oxidation of clopidogrel Clopidogrel results in increased expression of CYP2B6 mRNA [Clopidogrel co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA |
CTD |
PMID:19812348 PMID:31312845 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
multiple interactions increases oxidation increases metabolic processing decreases response to substance increases response to substance decreases metabolic processing affects abundance affects response to substance |
ISO |
ABCB1 gene affects the reaction [CYP2C19 gene affects the susceptibility to clopidogrel]; CYP2C19 gene affects the reaction [clopidogrel affects the phosphorylation of VASP protein]; CYP2C19 gene affects the susceptibility to [Adenosine Diphosphate co-treated with clopidogrel]; CYP2C19 gene polymorphism results in decreased metabolism of and results in decreased activity of clopidogrel; CYP2C19 gene SNP promotes the reaction [CYP2C19 gene SNP affects the susceptibility to clopidogrel]; CYP2C19 protein results in increased metabolism of and results in increased activity of clopidogrel; CYP2C19 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite; CYP2C9 gene affects the reaction [CYP2C19 gene affects the susceptibility to clopidogrel]; N-3-benzylnirvanol inhibits the reaction [CYP2C19 protein results in increased oxidation of clopidogrel]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased oxidation of clopidogrel]; P2RY12 gene SNP affects the reaction [CYP2C19 gene SNP affects the susceptibility to clopidogrel] CYP2C19 protein results in increased metabolism of clopidogrel CYP2C19 gene polymorphism results in decreased susceptibility to clopidogrel; CYP2C19 gene SNP results in decreased susceptibility to clopidogrel CYP2C19 gene polymorphism results in increased susceptibility to clopidogrel; CYP2C19 gene SNP results in increased susceptibility to clopidogrel CYP2C19 gene polymorphism results in decreased metabolism of clopidogrel; CYP2C19 gene SNP results in decreased metabolism of clopidogrel CYP2C19 gene polymorphism affects the abundance of clopidogrel metabolite CYP2C19 gene affects the susceptibility to clopidogrel; CYP2C19 gene polymorphism affects the susceptibility to clopidogrel; CYP2C19 gene SNP affects the susceptibility to clopidogrel |
CTD |
PMID:16772608 PMID:17697139 PMID:17900275 PMID:18532997 PMID:18577829 PMID:19106083 PMID:19106084 PMID:19170597 PMID:19429918 PMID:19463375 PMID:19496924 PMID:19576320 PMID:19706858 PMID:19812348 PMID:19926050 PMID:19934793 PMID:20083681 PMID:20166430 PMID:20180610 PMID:20217574 PMID:20620727 PMID:20978260 More...
|
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
multiple interactions |
ISO |
CYP2C8 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite |
CTD |
PMID:19170597 |
|
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions |
ISO |
CYP2D6 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite |
CTD |
PMID:19170597 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression increases response to substance increases degradation affects response to substance multiple interactions |
ISO |
Clopidogrel results in increased expression of CYP3A4 mRNA CYP3A4 protein results in increased susceptibility to Clopidogrel CYP3A4 protein results in increased degradation of Clopidogrel CYP3A4 gene polymorphism affects the susceptibility to Clopidogrel CYP3A4 protein results in increased oxidation of and results in increased cleavage of Clopidogrel metabolite; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased degradation of Clopidogrel]; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased susceptibility to Clopidogrel] |
CTD |
PMID:16645157 PMID:19170597 PMID:22651985 PMID:31312845 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
affects response to substance multiple interactions |
ISO |
CYP3A5 gene polymorphism affects the susceptibility to clopidogrel CYP3A5 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite |
CTD |
PMID:16754899 PMID:19170597 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of DUSP1 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Eif1a |
eukaryotic translation initiation factor 1A |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of EIF1A mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr18:39,325,695...39,338,043
Ensembl chr18:39,325,202...39,338,696
|
|
G |
F2 |
coagulation factor II, thrombin |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [F2 protein results in increased expression of SELP protein] |
CTD |
PMID:17043144 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
affects response to substance |
ISO |
F2R gene SNP affects the susceptibility to clopidogrel |
CTD |
PMID:16194864 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions |
ISO |
Clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of F3 protein] |
CTD |
PMID:30537341 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
Clopidogrel results in decreased expression of G6PC1 mRNA |
CTD |
PMID:31312845 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
ISO |
clopidogrel results in decreased expression of ICAM1 mRNA; clopidogrel results in decreased expression of ICAM1 protein |
CTD |
PMID:19155974 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of IL10RA mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of IL13 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] |
CTD |
PMID:30537341 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
increases expression |
ISO |
clopidogrel results in increased expression of IL4 mRNA |
CTD |
PMID:19155974 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression increases response to substance |
ISO |
clopidogrel promotes the reaction [Silicon Dioxide analog results in increased expression of IL6 protein] clopidogrel results in decreased expression of IL6 mRNA IL6 protein results in increased susceptibility to clopidogrel clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:17537833 PMID:19155974 PMID:24793913 PMID:24849676 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itga2 |
integrin subunit alpha 2 |
multiple interactions |
ISO |
ITGA2 gene SNP affects the susceptibility to [Aspirin co-treated with clopidogrel co-treated with Adenosine Diphosphate]; ITGA2 gene SNP affects the susceptibility to [Aspirin co-treated with clopidogrel co-treated with Epinephrine]; ITGA2 gene SNP affects the susceptibility to [Aspirin co-treated with clopidogrel] |
CTD |
PMID:15205592 PMID:16214444 |
|
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
|
|
G |
Itgb3 |
integrin subunit beta 3 |
decreases response to substance affects response to substance |
ISO |
ITGB3 gene SNP results in decreased susceptibility to clopidogrel ITGB3 gene SNP affects the susceptibility to clopidogrel |
CTD |
PMID:15166949 PMID:19530321 |
|
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Ltb4r |
leukotriene B4 receptor |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of LTB4R1 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr15:29,263,199...29,265,716
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK3 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mccc2 |
methylcrotonyl-CoA carboxylase subunit 2 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of MCCC2 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr 2:31,304,927...31,375,978
Ensembl chr 2:31,304,932...31,375,972
|
|
G |
Med1 |
mediator complex subunit 1 |
multiple interactions |
ISO |
Clopidogrel promotes the reaction [MED1 protein binds to NR1I3 protein alternative form] |
CTD |
PMID:31312845 |
|
NCBI chr10:83,145,538...83,189,260
Ensembl chr10:83,145,568...83,189,299
|
|
G |
Mir155 |
microRNA 155 |
increases expression |
ISO |
Clopidogrel results in increased expression of MIR155 mRNA |
CTD |
PMID:33208005 |
|
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir17 |
microRNA 17 |
decreases expression |
ISO |
Clopidogrel results in decreased expression of MIR17 mRNA |
CTD |
PMID:33208005 |
|
NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
|
|
G |
Mir363 |
microRNA 363 |
increases expression |
ISO |
Clopidogrel results in increased expression of MIR363 mRNA |
CTD |
PMID:33208005 |
|
NCBI chr X:132,421,791...132,421,877
Ensembl chr X:132,421,791...132,421,877
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases activity |
EXP |
clopidogrel results in decreased activity of MMP9 protein |
CTD |
PMID:20195827 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
Clopidogrel inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of MPO protein]; Clopidogrel inhibits the reaction [Lipopolysaccharides results in increased activity of MPO protein] |
CTD |
PMID:20133375 PMID:30537341 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
affects localization multiple interactions |
ISO |
Clopidogrel affects the localization of NR1I3 protein mutant form [Clopidogrel co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA; Clopidogrel binds to and results in increased activity of NR1I3 protein alternative form; Clopidogrel inhibits the reaction [ethyl (5-(diethylglycyl)-10,11-dihydro-5H-dibenzo(b,f)azepin-3-yl)carbamate results in decreased activity of NR1I3 protein]; Clopidogrel promotes the reaction [MED1 protein binds to NR1I3 protein alternative form] |
CTD |
PMID:31312845 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Ocln |
occludin |
decreases expression multiple interactions |
ISO |
clopidogrel results in decreased expression of OCLN protein SB 203580 inhibits the reaction [clopidogrel results in decreased expression of OCLN protein] |
CTD |
PMID:23220562 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
P2ry12 |
purinergic receptor P2Y12 |
multiple interactions increases response to substance affects response to substance |
ISO |
clopidogrel binds to and results in decreased activity of P2RY12 protein; P2RY12 gene SNP affects the reaction [CYP2C19 gene SNP affects the susceptibility to clopidogrel] P2RY12 protein results in increased susceptibility to clopidogrel P2RY12 gene affects the susceptibility to clopidogrel; P2RY12 gene SNP affects the susceptibility to clopidogrel; P2RY12 protein affects the susceptibility to clopidogrel |
CTD |
PMID:11413167 PMID:15933261 PMID:18404433 PMID:18485500 PMID:18577829 PMID:20031628 PMID:22129738 More...
|
|
NCBI chr 2:143,481,468...143,523,340
Ensembl chr 2:143,481,430...143,523,361
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
increases expression |
ISO |
Clopidogrel results in increased expression of PCK1 mRNA |
CTD |
PMID:31312845 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
decreases expression |
ISO |
clopidogrel results in decreased expression of PDGFB mRNA; clopidogrel results in decreased expression of PDGFB protein |
CTD |
PMID:19155974 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pon1 |
paraoxonase 1 |
affects response to substance multiple interactions |
ISO |
PON1 gene polymorphism affects the susceptibility to clopidogrel PON1 protein results in increased metabolism of and results in increased activity of clopidogrel |
CTD |
PMID:21170047 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Prkcb |
protein kinase C, beta |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of PRKCB mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Ran |
RAN, member RAS oncogene family |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of RAN mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
|
|
G |
S100a11 |
S100 calcium binding protein A11 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of S100A11 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
ISO |
Clopidogrel results in decreased expression of SCD mRNA |
CTD |
PMID:31312845 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sele |
selectin E |
decreases expression |
ISO |
clopidogrel results in decreased expression of SELE mRNA; clopidogrel results in decreased expression of SELE protein |
CTD |
PMID:19155974 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Selp |
selectin P |
multiple interactions decreases expression |
ISO |
Clopidogrel inhibits the reaction [F2 protein results in increased expression of SELP protein]; Clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of SELP protein] clopidogrel results in decreased expression of SELP mRNA; clopidogrel results in decreased expression of SELP protein |
CTD |
PMID:17043144 PMID:19155974 PMID:30537341 |
|
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
|
|
G |
Slc3a1 |
solute carrier family 3 member 1 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of SLC3A1 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr 6:9,608,169...9,641,881
Ensembl chr 6:9,608,178...9,641,907
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of STAT2 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
|
|
G |
Sucla2 |
succinate-CoA ligase ADP-forming subunit beta |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of SUCLA2 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr15:48,752,356...48,805,495
Ensembl chr15:48,752,312...48,805,138
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions increases expression |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of TGFB1 mRNA] clopidogrel results in increased expression of TGFB1 mRNA |
CTD |
PMID:19155974 PMID:19172522 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thbs1 |
thrombospondin 1 |
increases expression |
ISO |
clopidogrel results in increased expression of THBS1; clopidogrel results in increased expression of THBS1 mRNA; clopidogrel results in increased expression of THBS1 protein |
CTD |
PMID:9447704 PMID:11875746 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Thrsp |
thyroid hormone responsive |
increases expression |
ISO |
Clopidogrel results in increased expression of THRSP mRNA |
CTD |
PMID:31312845 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Tjp1 |
tight junction protein 1 |
decreases expression multiple interactions |
ISO |
clopidogrel results in decreased expression of TJP1 protein SB 203580 inhibits the reaction [clopidogrel results in decreased expression of TJP1 protein] |
CTD |
PMID:23220562 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tmem69 |
transmembrane protein 69 |
multiple interactions |
ISO |
clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of TMEM69 mRNA] |
CTD |
PMID:19172522 |
|
NCBI chr 5:130,004,888...130,008,466
Ensembl chr 5:130,004,901...130,010,655
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
ISO |
clopidogrel results in increased expression of TNF mRNA Clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:19155974 PMID:30537341 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
clopidogrel results in increased expression of TP53 mRNA; clopidogrel results in increased expression of TP53 protein |
CTD |
PMID:9447704 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vasp |
vasodilator-stimulated phosphoprotein |
multiple interactions |
ISO |
CYP2C19 gene affects the reaction [clopidogrel affects the phosphorylation of VASP protein] |
CTD |
PMID:16772608 |
|
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
|
|